Emerging vascular risk factors in women: Any differences from men?

Current Medicinal Chemistry

Volumn 22, Issue 31, 2015, Pages 3565-3579

  Katsiki, N ^a   Mikhailidis, D P ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Arterial stiffness; Inflammatory markers; Metabolic syndrome; Non alcoholic fatty liver disease; Vascular risk factors; Women

Indexed keywords

BIOLOGICAL MARKER; FIBRINOGEN; GLUCOSE; HOMOCYSTEINE; URIC ACID;

AGE DISTRIBUTION; ARTERIAL STIFFNESS; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY CALCIUM SCORE; DIABETES MELLITUS; DISEASE MARKER; DISEASE SEVERITY; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; FAMILY HISTORY; GLUCOSE METABOLISM; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATORY BOWEL DISEASE; ISCHEMIC HEART DISEASE; METABOLIC SYNDROME X; MICROALBUMINURIA; NONALCOHOLIC FATTY LIVER; OBESITY; PERIODONTITIS; PROSPECTIVE STUDY; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SLEEP DISORDERED BREATHING; SMOKING; URIC ACID BLOOD LEVEL; ADULT; BLOOD; COMPLICATION; FEMALE; INFLAMMATION; MALE; PATHOPHYSIOLOGY; VASCULAR DISEASES;

ADULT; BIOMARKERS; FEMALE; HUMANS; INFLAMMATION; MALE; PERIODONTITIS; RISK FACTORS; SEX FACTORS; URIC ACID; VASCULAR DISEASES;

EID: 84947940478     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867322666150904110053     Document Type: Article

References (237)

1. Shaw, L.J.; Bairey, M.C.N.; Pepine, C.J.; Reis, S.E.; Bittner, V.; Kelsey, S.F.; Olson, M.; Johnson, B.D.; Mankad, S.; Sharaf, B.L.; Rogers, W.J.; Wessel, T.R.; Arant, C.B.; Pohost, G.M.; Lerman, A.; Quyyumi, A.A.; Sopko, G. WISE Investigators. Insights from the NHLBISponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and genderoptimized diagnostic strategies. J. Am. Coll. Cardiol., 2006, 47 (3 Suppl), S4-S20.
2. Vassalle, C.; Simoncini, T.; Chedraui, P.; Perez-Lopez, F.R. Why sex matters: the biological mechanisms of cardiovascular disease. Gynecol. Endocrinol., 2012, 28 (9), 746-751.
3. Knowlton, A.A. Estrogen and cardiovascular disease: aging and estrogen loss at the heart of the matter? Future Cardiol., 2012, 8 (1), 9-12.
4. Kolovou, G.D.; Bilianou, H.G. Influence of aging and menopause on lipids and lipoproteins in women. Angiology, 2008, 59 (2 Suppl), 54S-57S.
5. Kolovou, G.D.; Kolovou, V.; Kostakou, P.M.; Mavrogeni, S. Body mass index, lipid metabolism and estrogens: their impact on coronary heart disease. Curr. Med. Chem., 2014, 21 (30), 3455-3465.
6. Xue, B.; Johnson, A.K.; Hay, M. Sex differences in angiotensin II-and aldosterone-induced hypertension: the central protective effects of estrogen. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2013, 305 (5), R459-R463.
7. Varlamov, O.; Bethea, C.L.; Roberts, C.T. Jr. Sex-specific differences in lipid and glucose metabolism. Front. Endocrinol. (Lausanne), 2015, 5, 241.
8. Wong, N.D.; Pio, J.; Valencia, R.; Thakal, G. Distribution of C-reactive protein and its relation to risk factors and coronary heart disease risk estimation in the National Health and Nutrition Examination Survey (NHANES) III. Prev. Cardiol., 2001, 4 (3), 109-114.
9. Delongui, F.; Kallaur, A.P.; Oliveira, S.R.; Bonametti, A.M.; Grion, C.M.; Morimoto, H.K.; Simao, A.N.; Magalhaes, G.G.; Reiche, E.M. Serum levels of high sensitive C reactive protein in healthy adults from Southern Brazil. J. Clin. Lab Anal., 2013, 27 (3), 207-210.
10. Shanahan, L.; Freeman, J.; Bauldry, S. Is very high Creactive protein in young adults associated with indicators of chronic disease risk? Psychoneuroendocrinology, 2014, 40, 76-85.
11. Yatsuya, H.; Jeffery, R.W.; Langer, S.L.; Mitchell, N.; Flood, A.P.; Welsh, E.M.; Jaeb, M.A.; Laqua, P.S.; Crowell, M.; Levy, R.L. Changes in C-reactive protein during weight loss and the association with changes in anthropometric variables in men and women: LIFE Study. Int. J. Obes. (Lond)., 2011, 35 (5), 684-691.
12. Ndrepepa, G.; Braun, S.; Cassese, S.; Fusaro, M.; King, L.; Kastrati, A.; Schmidt, R. C-reactive protein and prognosis in women and men with coronary artery disease after percutaneous coronary intervention. Cardiovasc. Revasc. Med., 2013, 14 (5), 264-269.
13. Dahl, K.; Ahmed, L.A.; Joakimsen, R.M.; Jorgensen, L.; Eggen, A.E.; Eriksen, E.F.; Bjornerem, A. High-sensitivity C-reactive protein is an independent risk factor for nonvertebral fractures in women and men: The Tromso Study. Bone, 2015, 72, 65-70.
14. Vetter, M.L.; Wadden, T.A.; Vinnard, C.; Moore, R.H.; Khan, Z.; Volger, S.; Sarwer, D.B.; Faulconbridge, L.F. Power-Up Research Group. Gender differences in the relationship between symptoms of depression and highsensitivity CRP. Int. J. Obes. (Lond)., 2013, 37 (Suppl 1), S38-S43.
15. Pruijm, M.; Vollenweider, P.; Mooser, V.; Paccaud, F.; Preisig, M.; Waeber, G.; Marques-Vidal, P.; Burnier, M.; Bochud, M. Inflammatory markers and blood pressure: sex differences and the effect of fat mass in the CoLaus Study. J. Hum. Hypertens., 2013, 27 (3), 169-175.
16. Ji, H.; Zheng, W.; Li, X.; Liu, J.; Wu, X.; Zhang, M.A.; Umans, J.G.; Hay, M.; Speth, R.C.; Dunn, S.E.; Sandberg, K. Sex-specific T-cell regulation of angiotensin IIdependent hypertension. Hypertension, 2014, 64 (3), 573-582.
17. Hellings, W.E.; Pasterkamp, G.; Verhoeven, B.A.; De Kleijn, D.P.; De Vries, J.P.; Seldenrijk, K.A.; Van den Broek, T.; Moll, F.L. Gender-associated differences in plaque phenotype of patients undergoing carotid endarterectomy. J. Vasc. Surg., 2007, 45 (2), 289-296.
18. Krysiak, R.; Gdula-Dymek, A.; Marek, B.; Okopień, B. Comparison of the effects of hypolipidemic treatment on monocyte proinflammatory cytokine release in men and women with type 2 diabetes and atherogenic dyslipidemia. Endokrynol. Pol., 2015, 66 (3), 224-230.
19. Orel, M.; Lichnovska, R.; Gwozdziewiczova, S.; Zlamalova, N.; Klementa, I.; Merkunova, A.; Hrebicek, J. Gender differences in tumor necrosis factor alpha and leptin secretion from subcutaneous and visceral fat tissue. Physiol. Res., 2004, 53 (5), 501-505.
20. Torcia, M.G.; Nencioni, L.; Clemente, A.M.; Civitelli, L.; Celestino, I.; Limongi, D.; Fadigati, G.; Perissi, E.; Cozzolino, F.; Garaci, E.; Palamara, A.T. Sex differences in the response to viral infections: TLR8 and TLR9 ligand stimulation induce higher IL10 production in males. PLoS One, 2012, 7 (6), e39853.
21. Goetzl, E.J.; Huang, M.C.; Kon, J.; Patel, K.; Schwartz, J.B.; Fast, K.; Ferrucci, L.; Madara, K.; Taub, D.D.; Longo, D.L. Gender specificity of altered human immune cytokine profiles in aging. FASEB J., 2010, 24 (9), 3580-3589.
22. Prather, A.A.; Carroll, J.E.; Fury, J.M.; McDade, K.K.; Ross, D.; Marsland, A.L. Gender differences in stimulated cytokine production following acute psychological stress. Brain Behav. Immun., 2009, 23 (5), 622-628.
23. Demerath, E.; Towne, B.; Blangero, J.; Siervogel, R.M. The relationship of soluble ICAM-1, VCAM-1, P-selection and E-selection to cardiovascular disease risk factors in healthy men and women. Ann. Hum. Biol., 2001, 28 (6), 664-678.
24. Corcoran, M.P.; Meydani, M.; Lichtenstein, A.H.; Schaefer, E.J.; Dillard, A.; Lamon-Fava, S. Sex hormone modulation of proinflammatory cytokine and C-reactive protein expression in macrophages from older men and postmenopausal women. J. Endocrinol., 2010, 206 (2), 217-224.
25. Bidulescu, A.; Liu, J.; Hickson, D.A.; Hairston, K.G.; Fox, E.R.; Arnett, D.K.; Sumner, A.E.; Taylor, H.A.; Gibbons, G.H. Gender differences in the association of visceral and subcutaneous adiposity with adiponectin in African Americans: the Jackson Heart Study. BMC Cardiovasc. Disord., 2013, 13, 9.
26. Riestra, P.; Garcia-Anguita, A.; Ortega, L.; Garces, C. Relationship of adiponectin with sex hormone levels in adolescents. Horm. Res. Paediatr., 2013, 79 (2), 83-87.
27. Alehagen, U.; Vorkapic, E.; Ljungberg, L.; Lanne, T.; Wagsater, D. Gender difference in adiponectin associated with cardiovascular mortality. BMC Med. Genet., 2015, 16, 37.
28. Eglit, T.; Lember, M.; Ringmets, I.; Rajasalu, T. Gender differences in serum high-molecular-weight adiponectin levels in metabolic syndrome. Eur. J. Endocrinol., 2013, 168 (3), 385-391.
29. Song, H.J.; Oh, S.; Quan, S.; Ryu, O.H.; Jeong, J.Y.; Hong, K.S.; Kim, D.H. Gender differences in adiponectin levels and body composition in older adults: hallym aging study. BMC Geriatr., 2014, 14, 8.
30. Chai, S.B.; Sun, F.; Nie, X.L.; Wang, J. Leptin and coronary heart disease: a systematic review and meta-analysis. Atherosclerosis, 2014, 233 (1), 3-10.
31. Chen, G.C.; Qin, L.Q.; Ye, J.K. Leptin levels and risk of type 2 diabetes: gender-specific meta-analysis. Obes. Rev., 2014, 15 (2), 134-142.
32. Asarian, L.; Geary, N. Sex differences in the physiology of eating. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2013, 305 (11), R1215-R1267.
33. Nedungadi, T.P.; Clegg, D.J. Sexual dimorphism in body fat distribution and risk for cardiovascular diseases. J. Cardiovasc. Transl. Res., 2009, 2 (3), 321-327.
34. Zhang, Y.; Zitsman, J.L.; Hou, J.; Fennoy, I.; Guo, K.; Feinberg, J.; Leibel, R.L. Fat cell size and adipokine expression in relation to gender, depot, and metabolic risk factors in morbidly obese adolescents. Obesity (Silver Spring)., 2014, 22 (3), 691-697.
35. Katsiki, N.; Mikhailidis, D.P.; Gotzamani-Psarrakou, A.; Didangelos, T.P.; Yovos, J.G.; Karamitsos, D.T. Effects of improving glycemic control with insulin on leptin, adiponectin, ghrelin and neuropeptidey levels in patients with type 2 diabetes mellitus: a pilot study. Open Cardiovasc. Med. J., 2011, 5, 136-147.
36. Kolovou, G.; Kolovou, V.; Koutelou, M.; Mavrogeni, S. Atherosclerotic and non atherosclerotic coronary heart disease in women. Curr. Pharm, Des., 2015,.
37. Marchi, R.; Marcos, L.; Paradisi, I. Comparison by sex between thrombin generation and fibrin network character istics in a healthy population. Clin. Chim. Acta, 2015, 441, 86-89.
38. Koltai, K.; Papp, J.; Kenyeres, P.; Feher, G.; Tibold, A.; Alexy, T.; Marton, Z.; Kesmarky, G.; Toth, K. Gender differences in hemorheological parameters and in vitro platelet aggregation in acetylsalicylic acid and clopidogrel treated vascular patients. Biorheology, 2014, 51 (2-3), 197-206.
39. Roy-O'Reilly, M.; McCullough, L.D. Sex differences in stroke: the contribution of coagulation. Exp. Neurol., 2014, 259, 16-27.
40. Alzahrani, S.H.; Hess, K.; Price, J.F.; Strachan, M.; Baxter, P.D.; Cubbon, R.; Phoenix, F.; Gamlen, T.; Ariens, R.A.; Grant, P.J.; Ajjan, R.A. Gender-specific alterations in fibrin structure function in type 2 diabetes: associations with cardiometabolic and vascular markers. J. Clin. Endocrinol. Metab., 2012, 97 (12), E2282-E2287.
41. Mehta, R.H.; Stebbins, A.S.; Lopes, R.D.; Califf, R.M.; Pieper, K.S.; Armstrong, P.W.; Vande, W. F.; Hochman, J.S.; White, H.D.; Topol, E.J.; Alexander, J.H.; Granger, C.B. Comparison of incidence of bleeding and mortality of men versus women with ST-elevation myocardial infarction treated with fibrinolysis. Am. J. Cardiol., 2012, 109 (3), 320-326.
42. Kent, D.M.; Price, L.L.; Ringleb, P.; Hill, M.D.; Selker, H.P. Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials. Stroke, 2005, 36 (1), 62-65.
43. Shah, S.H.; Liebeskind, D.S.; Saver, J.L.; Starkman, S.; Vinuela, F.; Duckwiler, G.; Jahan, R.; Kim, D.; Sanossian, N.; Vespa, P.; Ovbiagele, B. Influence of gender on outcomes after intra-arterial thrombolysis for acute ischemic stroke. Neurology, 2006, 66 (11), 1745-1746.
44. Schoenhard, J.A.; Asselbergs, F.W.; Poku, K.A.; Stocki, S.A.; Gordon, S.; Vaughan, D.E.; Brown, N.J.; Moore, J.H.; Williams, S.M. Male-female differences in the genetic regulation of t-PA and PAI-1 levels in a Ghanaian population. Hum. Genet., 2008, 124 (5), 479-488.
45. Asselbergs, F.W.; Williams, S.M.; Hebert, P.R.; Coffey, C.S.; Hillege, H.L.; Navis, G.; Vaughan, D.E.; van Gilst, W.H.; Moore, J.H. Epistatic effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels. Genomics, 2007, 89 (3), 362-369.
46. Rauch, U. Gender differences in anticoagulation and antithrombotic therapy. Handb. Exp. Pharmacol., 2012, (214), 523-542.
47. Capodanno, D.; Angiolillo, D.J. Impact of race and gender on antithrombotic therapy. Thromb. Haemost., 2010, 104 (3), 471-484.
48. Marcucci, R.; Cioni, G.; Giusti, B.; Fatini, C.; Rossi, L.; Pazzi, M.; Abbate, R. Gender and anti-thrombotic therapy: from biology to clinical implications. J. Cardiovasc. Transl. Res., 2014, 7 (1), 72-81.
49. Zuern, C.S.; Lindemann, S.; Gawaz, M. Platelet function and response to aspirin: gender-specific features and implications for female thrombotic risk and management. Semin. Thromb. Hemost., 2009, 35 (3), 295-306.
50. Gutierrez-Chico, J.L; Mehilli, J. Gender differences in cardiovascular therapy: focus on antithrombotic therapy and percutaneous coronary intervention. Drugs, 2013, 73 (17), 1921-1933.
51. Dos Santos, R.L.; Da Silva F.B.; Ribeiro, R.F.; Jr Stefanon, I. Sex hormones in the cardiovascular system. Horm. Mol. Biol. Clin. Investig., 2014, 18 (2), 89-103.
52. Skaug, E.A.; Aspenes, S.T.; Oldervoll, L.; Morkedal, B.; Vatten, L.; Wisloff, U.; Ellingsen, O. Age and gender differences of endothelial function in 4739 healthy adults: the HUNT3 Fitness Study. Eur. J. Prev. Cardiol., 2013, 20 (4), 531-540.
53. Suboc, T.M.; Dharmashankar, K.; Wang, J.; Ying, R.; Couillard, A.; Tanner, M.J.; Widlansky, M.E. Moderate obesity and endothelial dysfunction in humans: Influence of gender and systemic inflammation. Physiol. Rep., 2013, 1 (3).
54. Yao, F.; Liu, Y.; Liu, D.; Wu, S.; Lin, H.; Fan, R.; Li, C. Sex differences between vascular endothelial function and carotid intima-media thickness by framingham risk score. J. Ultrasound Med., 2014, 33 (2), 281-286.
55. Schneider, M.P.; Ritt, M.; Raff, U.; Ott, C.; Schmieder, R.E. Gender is related to alterations of renal endothelial function in type 2 diabetes. Nephrol. Dial. Transplant, 2009, 24 (11), 3354-3359.
56. Tehrani, F.R.; Behboudi-Gandevani, S.; Ghasemi, A.; Azizi, F. Menopause status as the main factor explaining the gender differences of serum nitric oxide concentrations in middle-aged population. Arch. Gynecol. Obstet., 2015, 291 (1), 159-163.
57. Majmudar, N.G.; Robson, S.C.; Ford, G.A. Effects of the menopause, gender, and estrogen replacement therapy on vascular nitric oxide activity. J. Clin. Endocrinol. Metab., 2000, 85 (4), 1577-1583.
58. Huxley, V.H.; Wang, J. Cardiovascular sex differences influencing microvascular exchange. Cardiovasc. Res., 2010, 87 (2), 230-242.
59. Must, A.; Jacques, P.F.; Rogers, G.; Rosenberg, I.H.; Selhub, J. Serum total homocysteine concentrations in children and adolescents: results from the third National Health and Nutrition Examination Survey (NHANES III). J. Nutr., 2003, 133 (8), 2643-2649.
60. Sassi, S.; Cosmi, B.; Palareti, G.; Legnani, C.; Grossi, G.; Musolesi, S.; Coccheri, S. Influence of age, sex and vitamin status on fasting and post-methionine load plasma homocysteine levels. Haematologica, 2002, 87 (9), 957-964.
61. Stanisławska-Sachadyn, A.; Woodside, J.V.; Brown, K.S.; Young, I.S.; Murray, L.; McNulty, H.; Strain, J.J.; Boreham, C.A.; Scott, J.M.; Whitehead, A.S.; Mitchell, L.E. Evidence for sex differences in the determinants of homocysteine concentrations. Mol. Genet. Metab., 2008, 93 (4), 355-362.
62. Sheng, L.; Wu, C.; Bai, Y.Y.; Xiao, W.K.; Feng, D.; Ye, P. Plasma homocysteine levels are independently associated with alterations of large artery stiffness in men but not in women. J. Geriatr. Cardiol., 2015, 12 (3), 251-256.
63. Sadeghian, S.; Fallahi, F.; Salarifar, M.; Davoodi, G.; Mahmoodian, M.; Fallah, N.; Darvish, S.; Karimi, A. Tehran Heart Center. Homocysteine, vitamin B12 and folate levels in premature coronary artery disease. BMC Cardiovasc. Disord., 2006, 6, 38.
64. Lioudaki, E; Florentin, M.; Ganotakis, E.S.; Mikhailidis, D.P. Microalbuminuria: a neglected cardiovascular risk factor in non-diabetic individuals? Curr. Pharm. Des., 2013, 19 (27), 4964-4980.
65. Palatini, P.; Mos, L.; Santonastaso, M.; Saladini, F.; Benetti, E.; Mormino, P.; Bortolazzi, A.; Cozzio, S. Premenopausal women have increased risk of hypertensive target organ damage compared with men of similar age. J. Womens Health (Larchmt), 2011, 20 (8), 1175-1181.
66. Pointer, M.A.; Hicks, K.; Williams-Devane, C.; Wells, C.; Greene, N. Gender differences in preclinical markers of kidney injury in a rural north Carolina african-american cohort. Front. Public Health, 2015, 3, 7.
67. Shantha, G.P.; Kumar, A.A.; Bharadhi, M.K.; Arthur, P. Role of gender in the associations of microalbuminuria with inflammatory markers in hypertensive subjects: a cross sectional study. Kidney Blood Press Res., 2009, 32 (6), 434-439.
68. Warady, B.A.; Abraham, A.G.; Schwartz, G.J.; Wong, C.S.; Munoz, A.; Betoko, A.; Mitsnefes, M.; Kaskel, F; Greenbaum, L.A.; Mak, R.H.; Flynn, J.; Moxey-Mims, M.M.; Furth, S. Predictors of rapid progression of glomerular and nonglomerular kidney disease in children and adolescents: The chronic kidney disease in children (CKiD) cohort. Am. J. Kidney Dis., 2015, 65 (6), 878-888.
69. Silbiger, S.; Neugarten, J. Gender and human chronic renal disease. Gend. Med., 2008, 5 (Suppl A), S3-S10.
70. Hanai, K.; Babazono, T.; Yoshida, N.; Nyumura, I.; Toya, K.; Hayashi, T.; Bouchi, R.; Tanaka, N; Ishii, A; Iwamoto, Y. Gender differences in the association between HDL cholesterol and the progression of diabetic kidney disease in type 2 diabetic patients. Nephrol. Dial. Transplant., 2012, 27 (3),1070-1075.
71. Okada, K.; Yanai, M.; Takeuchi, K.; Matsuyama, K.; Nitta, K.; Hayashi, K.; Takahashi, S. Sex differences in the prevalence, progression, and improvement of chronic kidney disease. Kidney Blood Press Res., 2014, 39 (4), 279-288.
72. Barbieri, L.; Verdoia, M.; Schaffer, A.; Marino, P.; Suryapranata, H.; De Luca, G.; Novara atherosclerosis study group (NAS). Impact of sex on uric acid levels and its relationship with the extent of coronary artery disease: A single-centre study. Atherosclerosis, 2015, 241 (1), 241-248.
73. Shatat, I.F.; Abdallah, R.T.; Sas, D.J.; Hailpern, S.M. Serum uric acid in U.S. adolescents: distribution and relationship to demographic characteristics and cardiovascular risk factors. Pediatr. Res., 2012, 72 (1), 95-100.
74. Zhan, Y.; Dong, Y.; Tang, Z.; Zhang, F.; Hu, D.; Yu, J. Serum uric acid, gender, and low ankle brachial index in adults with high cardiovascular risk. Angiology, 2015 Jan 6. [Epub ahead of print]
75. Fang, J.I.; Wu, J.S.; Yang, Y.C.; Wang, R.H.; Lu, F.H.; Chang, C.J. High uric acid level associated with increased arterial stiffness in apparently healthy women. Atherosclerosis, 2014, 236 (2), 389-393.
76. Elsurer, R.; Afsar, B. Serum uric acid and arterial stiffness in hypertensive chronic kidney disease patients: sex-specific variations. Blood Press Monit., 2014, 19 (5), 271-279.
77. Du, T.; Sun, X.; Lu, H.; Lin, X.; Liu, Q.; Huo, R.; Yu, X. Associations of serum uric acid levels with cardiovascular health factors: differences by sex, age and body mass index in Chinese participants. Eur. J. Intern. Med., 2014, 25 (4), 388-393.
78. Ndrepepa, G.; Cassese, S.; Braun, S.; Fusaro, M.; King, L.; Tada, T.; Schomig, A.; Kastrati, A.; Schmidt, R. A genderspecific analysis of association between hyperuricaemia and cardiovascular events in patients with coronary artery disease. Nutr. Metab. Cardiovasc. Dis., 2013, 23 (12), 1195-1201.
79. Kawai, T; Ohishi, M.; Takeya, Y.; Onishi, M.; Ito, N.; Yamamoto, K.; Kamide, K.; Rakugi, H. Serum uric acid is an independent risk factor for cardiovascular disease and mortality in hypertensive patients. Hypertens. Res., 2012, 35 (11), 1087-1092.
80. Kawamoto, R.; Tabara, Y.; Kohara, K.; Kusunoki, T.; Abe, M.; Miki, T. Serum uric acid is more strongly associated with impaired fasting glucose in women than in men from a community-dwelling population. PLoS One, 2013, 8 (6), e65886.
81. Cipolli, J.A.; Ferreira-Sae, M.C.; Martins, R.P.; Pio-Magalhaes, J.A.; Bellinazzi, V.R.; Matos-Souza, J.R. Junior WN. Relationship between serum uric acid and internal carotid resistive index in hypertensive women: a crosssectional study. BMC Cardiovasc. Disord., 2012, 12, 52.
82. Katsiki, N.; Athyros, V.G.; Karagiannis, A.; Mikhailidis, D.P. Characteristics other than the diagnostic criteria associated with metabolic syndrome: an overview. Curr. Vasc. Pharmacol., 2014, 12 (4), 627-641.
83. Katsiki, N.; Athyros, V.G.; Karagiannis, A.; Mikhailidis, D.P. Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): a relationship with implications for vascular risk? Curr. Vasc. Pharmacol., 2011, 9 (6), 698-705.
84. Katsiki, N.; Karagiannis, A.; Athyros, V.G.; Mikhailidis, D.P. Hyperuricaemia: more than just a cause of gout? J. Cardiovasc. Med. (Hagerstown)., 2013, 14 (6), 397-402.
85. Zhang, Q.; Lou, S.; Meng, Z.; Ren, X. Gender and age impacts on the correlations between hyperuricemia and metabolic syndrome in Chinese. Clin. Rheumatol., 2011, 30 (6), 777-787.
86. Hwang, I.C.; Suh, S.Y.; Suh, AR..; Ahn, H.Y. The relationship between normal serum uric acid and nonalcoholic fatty liver disease. J. Korean Med. Sci., 2011, 26 (3), 386-391.
87. Toth, P.P. Insulin resistance, small LDL particles, and risk for atherosclerotic disease. Curr. Vasc. Pharmacol., 2014, 12 (4), 653-657.
88. Nikolic, D.; Katsiki, N.; Montalto, G.; Isenovic, E.R.; Mikhailidis, D.P.; Rizzo, M. Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approaches. Nutrients, 2013, 5 (3), 928-948.
89. Mikhailidis, D.P.; Elisaf, M.; Rizzo, M.; Berneis, K.; Griffin, B.; Zambon, A.; Athyros, V.; de Graaf, J.; Marz, W.; Parhofer, K.G.; Rini, G.B.; Spinas, G.A.; Tomkin, G.H.; Tselepis, A.D.; Wierzbicki, A.S.; Winkler, K.; Florentin, M.; Liberopoulos, E. "European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: executive summary. Curr. Vasc. Pharmacol., 2011, 9 (5), 531-532.
90. Mikhailidis, D.P.; Elisaf, M.; Rizzo, M.; Berneis, K.; Griffin, B.; Zambon, A.; Athyros, V; de Graaf, J.; Marz, W.; Parhofer, K.G.; Rini, G.B.; Spinas, G.A.; Tomkin, G.H.; Tselepis, A.D.; Wierzbicki, A.S.; Winkler, K.; Florentin, M.; Liberopoulos, E. "European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses. Curr. Vasc. Pharmacol., 2011, 9 (5), 533-571.
91. Russo, G.T.; Giandalia, A.; Romeo, E.L.; Marotta, M.; Alibrandi, A.; De Francesco, C.; Horvath, K.V.; Asztalos, B.; Cucinotta, D. Lipid and non-lipid cardiovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart disease. J. Endocrinol. Invest., 2014, 37 (3), 261-268.
92. Gentile, M.; Panico, S.; Mattiello, A.; Ubaldi, S.; Iannuzzo, G.; De Michele, M.; Iannuzzi, A.; Rubba, P. Association between small dense LDL and early atherosclerosis in a sample of menopausal women. Clin. Chim. Acta, 2013, 426, 1-5.
93. Gentile, M.; Panico, S.; Jossa, F.; Mattiello, A.; Ubaldi, S.; Marotta, G.; Pauciullo, P.; Rubba, P. Small dense LDL particles and metabolic syndrome in a sample of middle-aged women. Findings from Progetto Atena. Clin. Chim. Acta, 2008, 388 (1-2), 179-183.
94. Sancho-Rodriguez, N.; Aviles-Plaza, F.V.; Granero-Fernandez, E; Hernandez-Martinez, A.M.; Albaladejo-Oton, M.D.; Martinez-Mernandez, P.; Parra-Pallares, S. Observational study of lipid profile and LDL particle size in patients with metabolic syndrome. Lipids Health Dis., 2011, 10, 162.
95. Vekic, J.; Topic, A.; Zeljkovic, A.; Jelic-Ivanovic, Z.; Spasojevic-Kalimanovska, V. LDL and HDL subclasses and their relationship with Framingham risk score in middle aged Serbian population. Clin. Biochem., 2007, 40 (5-6), 310-316.
96. Decewicz, D.J.; Neatrour, D.M.; Burke, A.; Haberkorn, M.J.; Patney, H.L.; Vernalis, M.N.; Ellsworth, D. L. Effects of cardiovascular lifestyle change on lipoprotein subclass profiles defined by nuclear magnetic resonance spectroscopy. Lipids Health Dis., 2009, 8, 26.
97. Sakabe, K.; Fukuda, N.; Fukuda, Y.; Wakayama, K.; Nada, T.; Morishita, S.; Shinohara, H.; Tamura, Y. Gender differences in short-term effects of atorvastatin on lipid profile, fibrinolytic parameters, and endothelial function. Nutr. Metab. Cardiovasc. Dis., 2008, 18 (3), 182-188.
98. Katsiki, N.; Athyros, V.G.; Karagiannis, A.; Mikhailidis, D.P. High-density lipoprotein, vascular risk, cancer and infection: a case of quantity and quality? Curr. Med. Chem., 2014, 21 (25), 2917-2926.
99. Otocka-Kmiecik, A.; Mikhailidis, D.P.; Nicholls, S.J.; Davidson, M.; Rysz, J.; Banach, M. Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease? Prog. Lipid Res., 2012, 51 (4), 314-324.
100. Florentin, M.; Liberopoulos, E.N.; Wierzbicki, A.S.; Mikhailidis, D.P. Multiple actions of high-density lipoprotein. Curr. Opin. Cardiol., 2008, 23 (4), 370-378.
101. Athyros, V.G.; Katsiki, N.; Karagiannis, A.; Mikhailidis, D.P. Should raising high-density lipoprotein cholesterol be a matter of debate? J. Cardiovasc. Med. (Hagerstown), 2012, 13 (4), 254-259.
102. Agouridis, A.P.; Banach, M.; Mikhailidis, D.P. Dysfunctional high-density lipoprotein: not only quantity but first of all quality? Arch. Med. Sci., 2015, 11 (1), 230-231.
103. Zhang, J.; Zhang, Y.; Liu, H.; Bai, H.; Wang, Y.; Jiang, C.; Fan, P. Antioxidant properties of high-density lipoproteins are impaired in women with polycystic ovary syndrome. Fertil. Steril., 2015, 103 (5), 1346-1354.
104. Woodard, G.A.; Brooks, M.M.; Barinas-Mitchell, E.; Mackey, R.H.; Matthews, K.A.; Sutton-Tyrrell, K. Lipids, menopause, and early atherosclerosis in Study of Women's Health Across the Nation Heart women. Menopause, 2011, 18 (4), 376-384.
105. Lamon-Fava, S.; Herrington, D.M.; Reboussin, D.M.; Sherman, M.; Horvath, K.; Schaefer, E.J.; Asztalos, B.F. Changes in remnant and high-density lipoproteins associated with hormone therapy and progression of coronary artery disease in postmenopausal women. Atherosclerosis, 2009, 205 (1), 325-330.
106. McMahon, M.; Grossman, J.; Skaggs, B.;, Fitzgerald, J.; Sahakian, L.; Ragavendra, N.; Charles-Schoeman, C.; Watson, K.; Wong, W.K.; Volkmann, E.; Chen, W.; Gorn, A.; Karpouzas, G.; Weisman, M.; Wallace, D.J.; Hahn, B.H. Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus. Arthritis Rheum., 2009, 60 (8), 2428-2437.
107. Anagnostis, P.; Stevenson, J.C.; Crook, D.; Johnston, D.; Godsland, I. Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractions. Maturitas, 2015, 81 (1), 62-68.
108. Onat, A.; Can, G.; Murat, S.; Cicek, G.; Ornek, E.; Yuksel, H. Clinical biomarkers of high-density lipoprotein dysfunction among middle-aged Turks. Anadolu Kardiyol Derg., 2012, 12 (8), 628-636.
109. Koschinsky M, Boffa M. Lipoprotein (a) as a therapeutic target in cardiovascular disease. Expert Opin. Ther. Targets, 2014, 18 (7), 747-757.
110. Lamon-Fava, S.; Diffenderfer, M.R.; Marcovina, S.M. Lipoprotein (a) metabolism. Curr. Opin. Lipidol., 2014, 25 (3), 189-193.
111. Hahmann, H.W.; Schatzer-Klotz, D.; Bunte, T.; Becker, D.; Schieffer, H.J. The significance of high levels of lipoprotein (a) compared with established risk factors in premature coronary artery disease: differences between men and women. Atherosclerosis, 1999, 144 (1), 221-228.
112. Bermudez, V.; Rojas, J.; Salazar, J.; Bello, L.; Anez, R.; Toledo, A.; Chacin, M.; Aguirre, M.; Villalobos, M; Chavez, M.; Martinez, M.S.; Torres, W.; Torres, Y.; Mejias, J.; Mengual, E.; Rojas, L.; Sanchez, de Rosales. M.; Quevedo, A.; Cano, R.; Cabrera, M.; Paris, R.; Lubo, A.; Montiel, M.; Cano, C. Variations of lipoprotein (a) levels in the metabolic syndrome: a report from the Maracaibo City Metabolic Syndrome Prevalence Study. J. Diabetes Res., 2013, 2013, 416451.
113. Malek,F.; Dvořak, J.; Skalnikova, V.; Mates, M.; Kmoniček, P.; Vavrova, Z.; Neužil, P. Correlation of lipoprotein ( a) with the extent of coronary artery disease in patients with established coronary atherosclerosis: gender differences. Eur. J. Prev. Cardiol., 2015, 22 (5), 603-605.
114. Stiel, G.M.; Reblin, T.; Buhrlen, M.; Lattermann, A.; Nienaber, C.A. Differences in lipoprotein (a) and apolipoprotein (a) levels in men and women with advanced coronary atherosclerosis. Coron. Artery Dis., 1995, 6 (4), 3473-3450.
115. Boden-Albala, B.; Kargman, D.E.; Lin, I.F.; Paik, M.C.; Sacco, R.L.; Berglund, L. Increased stroke risk and lipoprotein ( a) in a multiethnic community: the Northern Manhattan Stroke Study. Cerebrovasc. Dis., 2010, 30 (3), 237-243.
116. Kotani, K.; Sahebkar, A.; Serban, C.; Andrica, F.; Toth, P.P.; Jones, S.R.; Kostner, K.; Blaha, M.J.; Martin, S.; Rysz, J.; Glasser, S.; Ray, K.K.; Watts, G.F.; Mikhailidis, D.P.; Banach, M. Lipid and blood pressure meta-analysis collaboration (LBPMC) Group. Tibolone decreases lipoprotein ( a) levels in postmenopausal women: a systematic review and meta-analysis of 12 studies with 1009 patients. Atherosclerosis, 2015, 242 (1), 87-96.
117. Howard, B.V.; Rossouw, J.E. Estrogens and cardiovascular disease risk revisited: the Women's Health Initiative. Curr. Opin. Lipidol, 2013, 24 (6), 493-499.
118. Sarwar, N.; Danesh, J.; Eiriksdottir, G.; Sigurdsson, G.; Wareham, N.; Bingham, S.; Boekholdt, S.M.; Khaw, K.T.; Gudnason, V. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation, 2007, 115 (4), 450-458.
119. Meagher, E.A.Addressing cardiovascular disease in women: focus on dyslipidemia. J. Am. Board Fam. Pract., 2004, 17 (6), 424-437.
120. Knopp, R.H.; Paramsothy, P.; Retzlaff, B.M.; Fish, B.; Walden, C.; Dowdy, A.; Tsunehara, C.; Aikawa, K.; Cheung, M.C. Gender differences in lipoprotein metabolism and dietary response: basis in hormonal differences and implications for cardiovascular disease. Curr. Atheroscler. Rep., 2005, 7 (6), 472-479.
121. Furusyo, N.; Ai, M.; Okazaki, M.; Ikezaki, H.; Ihara, T.; Hayashi, T.; Hiramine, S.; Ura, K.; Kohzuma, T.; Schaefer, E.J.; Hayashi, J. Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women. Atherosclerosis, 2013, 231 (2), 238-245.
122. Kolovou,G.D.; Mikhailidis, D.P.; Kovar, J.; Lairon, D.; Nordestgaard, B.G.; Ooi, T.C.; Perez-Martinez, P.; Bilianou, H.; Anagnostopoulou, K.; Panotopoulos, G. Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement. Curr. Vasc. Pharmacol., 2011, 9 (3), 258-270.
123. Kolovou, G.D.; Mikhailidis, D.P.; Nordestgaard, B.G.; Bilianoum, H.; Panotopoulos, G. Definition of postprandial lipaemia. Curr. Vasc. Pharmacol., 2011, (3), 292-301.
124. Anagnostopoulou, K.K.; Kolovou, G.D.; Kostakou, P.M.; Mihas, C.; Hatzigeorgiou, G.; Marvaki, C.; Degiannis, D.; Mikhailidis, D.P.; Cokkinos, D.V. Sex-associated effect of CETP and LPL polymorphisms on postprandial lipids in familial hypercholesterolaemia. Lipids Health Dis., 2009, 8, 24.
125. Wang, X.; Magkos, F.; Mittendorfer, B. Sex differences in lipid and lipoprotein metabolism: it's not just about sex hormones. J. Clin. Endocrinol. Metab., 2011, 96 (4), 885-893.
126. Spoletini, I.; Vitale, C.; Pelliccia, F.; Fossati, C.; Rosano, G.M. Androgens and cardiovascular disease in postmenopausal women: a systematic review. Climacteric, 2014, 17 (6), 625-634.
127. Petto, J.; Vasques, L.M.; Pinheiro, R.L.; Giesta, Bde A.; Santos, A.C.; Gomes, Neto M.; Ladeia, A.M. Comparison of postprandial lipemia between women who are on oral contraceptive methods and those who are not. Arq. Bras Cardiol., 2014, 103 (3), 245-250.
128. Miyashita, M.; Takahashi, M.; Burns, S. Increased participation in weekend physical activity reduces postprandial lipemia in postmenopausal women. Int. J. Sports Med., 2014, 35 (13), 1059-1064.
129. Zeb, I.; Budoff, M. Coronary artery calcium screening: does it perform better than other cardiovascular risk stratification tools? Int. J. Mol. Sci., 2015, 16 (3), 6606-6620.
130. Xie, X.; Zhao, Y.; de Bock, G.H.; de Jong, P.A.; Mali, W.P.; Oudkerk, M.; Vliegenthart, R. Validation and prognosis of coronary artery calcium scoring in nontriggered thoracic computed tomography: systematic review and meta-analysis. Circ. Cardiovasc. Imaging, 2013, 6 (4), 514-521.
131. Thomas, D.M.; Divakaran, S.; Villines, T.C.; Nasir, K.; Shah, N.R.; Slim, A.M.; Blankstein, R.; Cheezum, M.K. Management of coronary artery calcium and coronary CTA findings. Curr. Cardiovasc. Imaging Rep., 2015, 8 (6), 18.
132. Oliveira, J.L.; Hirata, M.H.; Sousa, A.G.; Gabriel, F.S.; Hirata, T.D.; Tavares, Ida. S.; Melo, L.D.; Doria, Fde. S.; Sousa, A.C.; Pinto, I.M. Male gender and arterial hypertension are plaque predictors at coronary computed tomography angiography. Arq. Bras. Cardiol., 2015, 104 (5), 409-416.
133. Makaryus, A.N.; Sison, C.; Kohansieh, M.; Makaryus, J.N. Implications of gender difference in coronary calcification as assessed by CT coronary angiography. Clin. Med. Insights Cardiol., 2015, 8 (Suppl 4), 51-55.
134. Priester, T.; Ault, T.G.; Davidson, L.; Gress, R.; Adams, T.D.; Hunt, S.C.; Litwin, S.E. Coronary calcium scores 6 years after bariatric surgery. Obes. Surg., 2015, 25 (1), 90-96.
135. Koulaouzidis, G.; Charisopoulou, D.; Maffrett, S.; Tighe, M.; Jenkins, P.J.; McArthur, T. Differences in clinical profile of individuals with severe and markedly elevated coronary artery calcification detected by electron beam computed tomography. Angiology, 2013, 64 (6), 435-439.
136. Qasim, A.N.; Budharaju, V.; Mehta, N.N.; St Clair, C.; Farouk, S.; Braunstein, S.; Schutta, M.; Iqbal, N.; Rader, D.J.; Reilly, M.P. Gender differences in the association of C-reactive protein with coronary artery calcium in type-2 diabetes. Clin. Endocrinol. (Oxf)., 2011, 74 (1), 44-50.
137. Athyros, V.G.; Tziomalos, K.; Katsiki, N.; Doumas, M.; Karagiannis, A.; Mikhailidis, D.P. Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update. World J. Gastroenterol., 2015, 21 (22), 6820-6834.
138. Athyros, V.G.; Katsiki, N.; Doumas, M.; Karagiannis, A.; Mikhailidis, D.P. Effect of tobacco smoking and smoking cessation on plasma lipoproteins and associated major cardiovascular risk factors: a narrative review. Curr. Med. Res. Opin., 2013, 29 (10), 1263-1274.
139. Katsiki, N.; Athyros, V.G.; Karagiannis, A.; Mikhailidis, D.P. Metabolic syndrome and non-cardiac vascular diseases: an update from human studies. Curr. Pharm. Des., 2014, 20 (31), 4944-4952.
140. Koumaras, C.; Tzimou, M.; Stavrinou, E.; Griva, T.; Gossios, T.D.; Katsiki, N.; Athyros, V.G.; Mikhailidis, D.P.; Karagiannis, A. Role of antihypertensive drugs in arterial 'de-stiffening' and central pulsatile hemodynamics. Am. J. Cardiovasc. Drugs, 2012, 12 (3), 143-156.
141. Doonan, R.J.; Hausvater, A.; Scallanm, C.; Mikhailidis, D.P.; Pilote, L.; Daskalopoulou, S.S. The effect of smoking on arterial stiffness. Hypertens. Res. 2010, 33 (5), 398-410.
142. Seifalian, A.M.; Filippatos, T.D.; Joshi, J.; Mikhailidis, D.P. Obesity and arterial compliance alterations. Curr. Vasc. Pharmacol., 2010, 8 (2), 155-168.
143. Smulyan, H.; Lieber, A.; Safar, M.E. Hypertension, diabetes type II, and their association: Role of arterial stiffness. Am. J. Hypertens., 2015 Jul 8. pi: hpv107. [Epub ahead of print].
144. Papademetriou, V.; Katsiki, N.; Doumas, M.; Faselis, C. Halting arterial aging in patients with cardiovascular disease: hypolipidemic and antihypertensive therapy. Curr. Pharm. Des., 2014, 20 (40), 6339-6349.
145. Vlachopoulos, C.; Xaplanteris, P.; Aboyans, V.;,Brodmann, M.; Cifkova,, R.; Cosentino. F.; De Carlo, M.; Gallino, A.; Landmesser, U.; Laurent, S.; Lekakis, J.; Mikhailidis, D.P.; Naka, K.K.; Protogerou, A.D.; Rizzoni, D.; Schmidt-Trucksass, A.; Van Bortel, L.; Weber, T.; Yamashina, A.; Zimlichman, R.; Boutouyrie, P.; Cockcroft, J.; O'Rourke, M.; Park, J.B.; Schillaci, G.; Sillesen, H. Townsend, R.R. The role of vascular biomarkers for primary and secondary prevention. A position paper from the European society of cardiology working group on peripheral circulation: endorsed by the association for research into arterial structure and physiology (ARTERY) society. Atherosclerosis, 2015, 241 (2), 507-532.
146. Christensen, M.; Kronborg, C.J.; Knudsen, U.B. [139-POS] preeclampsia and arterial stiffness -A 10-year follow up of previous preeclamptic women. Pregnancy Hypertens. 2015 5 (1) 72-73.
147. Krzesiński, P.; Stańczyk, A.; Gielerak, G.; Piotrowicz, K. The hemodynamic patterns in hypertensive men and women of different age. J. Hum. Hypertens., 2015 Jul 2. [Epub ahead of print]
148. Wen, W.; Peng, B.; Tang, X.; Huang, H.X.; Wen, X.; Hu, S.;, Luo, R. Prevalence of high arterial stiffness and genderspecific differences in the relationships with classical cardiovascular risk factors. J. Atheroscler. Thromb., 2015, 22 (7), 706-707.
149. Russo, C.; Jin, Z.; Palmieri, V.; Homma, S.; Rundek, T.; Elkind, M.S.; Sacco, R.L.; Di, Tullio, M.R. Arterial stiffness and wave reflection: sex differences and relationship with left ventricular diastolic function. Hypertension, 2012, 60 (2), 362-368.
150. Moreau, K.L.; Hildreth, K.L. Vascular aging across the menopause transition in healthy women. Adv. Vasc. Med., 2014, 2014.
151. Marlatt, K.L.; Kelly, A.S.; Steinberger, J.; Dengel, D.R. The influence of gender on carotid artery compliance and distensibility in children and adults. J. Clin. Ultrasound., 2013, 41 (6), 340-346.
152. Ayer, J.; Harmer, J.A.; Marks, G.B.; Avolio, A.; Celermajer, D.S. Central arterial pulse wave augmentation is greater in girls than boys, independent of height. J. Hypertens., 2010, 28 (2), 306-313.
153. Hlaing, W.M.; Prineas, R.J. Arterial stiffness variations by gender in African-American and Caucasian children. J. Natl. Med. Assoc., 2006, 98 (2), 181-189.
154. Ayyavoo, A.; Derraik, J.G.; Hofman, P.L.; Biggs, J.; Cutfield, W.S. Metabolic, cardiovascular and anthropometric differences between prepubertal girls and boys. Clin. Endocrinol. (Oxf)., 2014, 81 (2), 238-243.
155. Driziene, Z.; Jakutiene, E.; Stakisaitis, D.; Pundziene, B.; Sveikata, A. Characteristics of gender-related circadian arterial blood pressure in healthy adolescents. Medicina (Kaunas)., 2008, 44 (10), 768-774.
156. Kagan, A.; Faibel, H.; Ben-Arie, G.; Granevitze, Z.; Rapoport, J. Gender differences in ambulatory blood pressure monitoring profile in obese, overweight and normal subjects. J. Hum. Hypertens., 2007, 21 (2), 128-134.
157. Wang, X.; Poole, J.C.; Treiber, F.A.; Harshfield, G.A.; Hanevold, C.D.; Snieder, H. Ethnic and gender differences in ambulatory blood pressure trajectories: results from a 15-year longitudinal study in youth and young adults. Circulation, 2006, 114 (25), 2780-2787.
158. Shim, I.K.; Cho, K.I.; Kim, H.S.; Heo, J.H.; Cha, T.J. Impact of gender on the association of epicardial fat thickness, obesity, and circadian blood pressure pattern in hypertensive patients. J. Diabetes Res., 2015, 2015, 924539.
159. Stern, R.; Tattersall, M.C.; Gepner, A.D.; Korcarz, C.E.; Kaufman, J.; Colangelo, L.A.; Liu, K.; Stein, J.H. Sex differences in predictors of longitudinal changes in carotid artery stiffness: the Multi-Ethnic Study of Atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 2015, 35 (2), 478-484.
160. Omboni, S.; Posokhov, I.N.; Rogoza, A.N. 3D.05: Relationship between 24-hour blood pressure variability and 24-Hour aortic pressure and stiffness in hypertensive patients. J. Hypertens., 2015, 33 (Suppl 1), e41-e42.
161. Caviezel, S.; Dratva, J.; Schaffner, E.; Schindler, C.; Zemp Stutz, E.; de Groot, E.; Burdet, L.; Rothe, T.; Pons, M.; Gaspoz, J.M.; Rochat, T.; Kunzli, N.; Probst-Hensch, N.; Schmidt-Trucksass, A. Sex-specific associations of cardiovascular risk factors with carotid stiffness-results from the SAPALDIA cohort study. Atherosclerosis, 2014, 235 (2), 576-584.
162. Igase, M.; Kohara, K.; Tabara, Y.; Nagai, T.; Ochi, N.; Kido, T.; Ochi, M.; Miki, T. Low-dose rosuvastatin improves the functional and morphological markers of atherosclerosis in asymptomatic postmenopausal women with dyslipidemia. Menopause, 2012, 19 (12), 1294-1299.
163. Matsui, S.; Yasui, T.; Tani, A.; Kato, T.; Uemura, H.; Kuwahara, A.; Matsuzaki, T.; Arisawa, K.; Irahara, M. Effect of ultra-low-dose estradiol and dydrogesterone on arterial stiffness in postmenopausal women. Climacteric, 2014, 17 (2), 191-196.
164. Giannoglou, G.D.; Chatzizisis, Y.S.; Zamboulis, C.; Parcharidis, G.E.; Mikhailidis, D.P.; Louridas, G.E. Elevated heart rate and atherosclerosis: an overview of thepathogenetic mechanisms. Int. J. Cardiol., 2008, 126 (3), 302-312.
165. Niessen, L.C.; Gibson, G.; Kinnunen, T.H. Women's oral health: why sex and gender matter. Dent. Clin. North Am., 2013, 57 (2), 181-194.
166. Shiau, H.J.; Reynolds, M.A. Sex differences in destructive periodontal disease: exploring the biologic basis. J. Periodontol., 2010, 81 (11), 1505-1517.
167. Persson, G.R.; Persson, R.E.; Hollender, L.G.; Kiyak, H.A. The impact of ethnicity, gender, and marital status on periodontal and systemic health of older subjects in the Trials to Enhance Elders' Teeth and Oral Health (TEETH). J. Periodontol., 2004, 75 (6), 817-823.
168. Zi, M.Y.; Longo, P.L.; Bueno-Silva, B.; Mayer, M.P. Mechanisms involved in the association between periodontitis and complications in pregnancy. Front. Public Health, 2015, 2, 290.
169. Kim, A.J.; Lo, A.J.; Pullin, D.A.; Thornton-Johnson, D.S.; Karimbux, N.Y. Scaling and root planing treatment for periodontitis to reduce preterm birth and low birth weight: a systematic review and meta-analysis of randomized controlled trials. J. Periodontol., 2012, 83 (12), 1508-1519.
170. Furuta, M.; Shimazaki, Y.; Takeshita, T.; Shibat, Y.; Akifusa, S.; Eshima, N.; Kiyohara, Y.; Ninomiya, T.; Hirakawa, Y.; Mukai, N.; Nagata, M.; Yamashita, Y. Gender differences in the association between metabolic syndrome and periodontal disease: the Hisayama Study. J. Clin. Periodontol., 2013, 40 (8), 743-752.
171. Kiedrowicz, M.; Dembowska, E.; Banach, J.; Safranow, K.; Pynka, S. A comparison of the periodontal status in patients with type 2 diabetes based on glycated haemoglobin levels and other risk factors. Adv. Med Sci., 2015, 60 (1), 156-161.
172. Katsiki, N.; Athyros, V.G.; Karagiannis, A.; Wierzbicki, A.S.; Mikhailidis, D.P. Should we expand the concept of coronary heart disease equivalents? Curr. Opin. Cardiol., 2014, 29 (4), 389-395.
173. Desvarieux, M.; Schwahn, C.; Volzke, H.; Demmer, R.T.; Ludemann, J.; Kessler, C.; Jacobs, D.R. Jr, John U.; Kocher, T. Gender differences in the relationship between periodontal disease, tooth loss, and atherosclerosis. Stroke, 2004, 35 (9), 2029-2035.
174. Grau, A.J.; Becher, H.; Ziegler, C.M.; Lichy, C.; Buggle, F.; Kaiser, C.; Lutz, R.; Bultmann, S.; Preusch, M.; Dorfer, C.E. Periodontal disease as a risk factor for ischemic stroke. Stroke, 2004, 35 (2), 496-501.
175. Bloemenkamp, D.G.; van den Bosch, M.A.; Mali, W.P.; Tanis, B.C.; Rosendaal, F.R.; Kemmeren, J.M.; Algra, A.; Visseren, F.L.; van der Graaf, Y. Novel risk factors for peripheral arterial disease in young women. Am. J. Med., 2002, 113 (6), 462-467.
176. Herzog, D.; Buehr, P.; Koller, R.; Rueger, V.; Heyland, K.; Nydegger, A.; Spalinger, J.; Schibli, S.; Braegger, C.P. Swiss IBD Cohort Study Group. Gender differences in paediatric patients of the swiss inflammatory bowel disease cohort study. Pediatr. Gastroenterol. Hepatol. Nutr., 2014, 17 (3), 147-154.
177. Sankaran-Walters, S.; Macal, M.; Grishina, I.; Nagy, L.; Goulart, L.; Coolidge, K.; Li, J.; Fenton, A.; Williams, T.; Miller, M.K.; Flamm, J.; Prindiville, T.; George, M.; Dandekar, S. Sex differences matter in the gut: effect on mucosal immune activation and inflammation. Biol. Sex Differ., 2013, 4 (1), 10.
178. Law, S.T.; Li, K.K. Gender-related differences in clinical course of crohn?s disease in an Asian population: a retrospective cohort review. Arq. Gastroenterol., 2014, 51 (2), 90-96.
179. Zelinkova, Z.; Bultman, E.; Vogelaar, L.; Bouziane, C.; Kuipers, E.J.; van der, Woude, C.J. Sex-dimorphic adverse drug reactions to immune suppressive agents in inflammatory bowel disease. World J. Gastroenterol., 2012, 18 (47), 6967-6973.
180. Hauser, G.; Tkalcić, M.; Stimac, D.; Milić, S.; Sincić, B.M. Gender related differences in quality of life and affective status in patients with inflammatory bowel disease. Coll. Antropol., 2011, 35 (Suppl 2), 203-207.
181. Okoro, N.I.; Kane, S.V. Gender-related issues in the female inflammatory bowel disease patient. Expert Rev. Gastroenterol. Hepatol., 2009, 3 (2),145-154.
182. Singh, S.; Kullo, I.J.; Pardi, D.S.; Loftus, E.V. Jr. Epidemiology, risk factors and management of cardiovascular dis eases in IBD. Nat. Rev. Gastroenterol. Hepatol., 2015, 12 (1), 26-35.
183. Gonzaga, C.; Bertolami, A.; Bertolami, M.; Amodeo, C.; Calhoun, D. Obstructive sleep apnea, hypertension and cardiovascular diseases. J. Hum. Hypertens., 2015, Mar 12. doi: 10.1038/jhh.2015.15. [Epub ahead of print].
184. Xie, W.; Zheng, F.; Song, X. Obstructive sleep apnea and serious adverse outcomes in patients with cardiovascular or cerebrovascular disease: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore), 2014, 93 (29), e336.
185. Kostapanos, M.S.; Mikhailidis, D.P.; Elisaf, M.S.; Steiropoulos, P.; Papanas, N. Obstructive sleep apnoea syndrome and cardiovascular risk. Arch. Med. Sci., 2012, 8 (6), 1115-1116.
186. Monahan, K.; Redline, S. Role of obstructive sleep apnea in cardiovascular disease. Curr. Opin. Cardiol., 2011, 26 (6), 541-547.
187. Litvin, A.Y.; Sukmarova, Z.N.; Elfimova, E.M.; Aksenova, A.V.; Galitsin, P.V.; Rogoza, A.N.; Chazova, I.E. Effects of CPAP on "vascular" risk factors in patients with obstructive sleep apnea and arterial hypertension. Vasc. Health Risk Manag., 2013, 9, 229-235.
188. Ralls, F.M.; Grigg-Damberger, M. Roles of gender, age, race/ethnicity, and residential socioeconomics in obstructive sleep apnea syndromes. Curr. Opin. Pulm. Med., 2012, 18 (6), 568-573.
189. Lin, C.M.; Davidson, T.M.; Ancoli-Israel, S. Gender differences in obstructive sleep apnea and treatment implications. Sleep Med. Rev., 2008, 12 (6), 481-496.
190. Valipour, A. Gender-related differences in the obstructive sleep apnea syndrome. Pneumologie, 2012, 66 (10), 584-588.
191. Aldhoon-Hainerova, I.; Zamrazilova, H.; Dušatkova, L.; Sedlačkova, B.; Hlavaty, P.; Hill, M.; Hampl, R.; Kunešova, M.; Hainer, V. Glucose homeostasis and insulin resistance: prevalence, gender differences and predictors in adolescents. Diabetol. Metab. Syndrom., 2014, 6 (1), 100.
192. Hagman, E.; Reinehr, T.; Kowalski, J.; Ekbom, A.; Marcus, C.; Holl, R.W. Impaired fasting glucose prevalence in two nationwide cohorts of obese children and adolescents. Int. J. Obes (Lond)., 2014, 38 (1), 40-45.
193. van Genugten, R.E.; Utzschneider, K.M.; Tong, J.; Gerchman, F.; Zraika, S.; Udayasankar, J.; Boyko, E.J.; Fujimoto, W.Y.; Kahn, S.E. American Diabetes Association GENNID Study Group. Effects of sex and hormone replacement therapy use on the prevalence of isolated impaired fasting glucose and isolated impaired glucose tolerance in subjects with a family history of type 2 diabetes. Diabetes, 2006, 55 (12), 3529-3535.
194. Basu, R.; Dalla, M. C.; Campioni, M.; Basu, A.; Klee, G.; Toffolo, G.; Cobelli, C.; Rizza, R.A. Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction. Diabetes, 2006, 55 (7), 2001-2014.
195. Anderwald, C.; Gastaldelli, A.; Tura, A.; Krebs, M.; Promintzer-Schifferl, M.; Kautzky-Willer, A.; Stadler, M.; DeFronzo, R.A.; Pacini, G.; Bischof, M.G. Mechanism and effects of glucose absorption during an oral glucose tolerance test among females and males. J. Clin. Endocrinol. Metab., 2011, 96 (2), 515-524.
196. Sicree, R.A.; Zimmet, P.Z.; Dunstan, D.W.; Cameron, A.J.; Welborn, T.A.; Shaw, J.E. Differences in height explain gender differences in the response to the oral glucose tolerance test-the Aus. Diab Study. Diabet. Med., 2008, 25 (3), 296-302.
197. DeFronzo, R.A.; Abdul-Ghani, M. Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose. Am. J. Cardiol., 2011, 108 (3 Suppl), 3B-24B.
198. Filippatos, T.D.; Rizos, E.C.; Gazi, I.F.; Lagos, K.; Agouridis, D.; Mikhailidis, D.P.; Elisaf, M.S. Differences in metabolic parameters and cardiovascular risk between American Diabetes Association and World Health Organization definition of impaired fasting glucose in European Caucasian subjects: a cross-sectional study. Arch. Med. Sci., 2013, 9 (5), 788-795.
199. Dotevall, A.; Rosengren, A.; Bartnik, M.; Malmberg, K.; Ohrvik, J.; Simoons M.; Ryden, L. European Heart Survey Investigators. Sex-related aspects on abnormal glucose regulation in patients with coronary artery disease. Eur. Heart J., 2007, 28 (3), 310-315.
200. Zheng, J.; Gao, Y.; Jing, Y.; Zhou, X.; Shi, Y.; Li, Y.; Wang, L.; Wang, R.; Li, M.; Xiao, C.; Li, Y.; Li, R. Gender differences in the relationship between plasma lipids and fasting plasma glucose in non-diabetic urban Chinese population: a cross-section study. Front. Med., 2014, 8 (4), 477-483.
201. Carnevale Schianca, G.P.; Fra, G.P.; Colli, E.; Bigliocca, M.; Mella, R.; Scaglia, E.; Bartoli, E. Sex differences in lipid profiles in relation to the progression of glucose abnormalities. J. Diabetes, 2012, 4 (1), 95-101.
202. Saltevo, J.; Kautiainen, H.; Vanhala, M. Gender differences in adiponectin and low-grade inflammation among individuals with normal glucose tolerance, prediabetes, and type 2 diabetes. Gend. Med., 2009, 6 (3), 463-470.
203. Evangelista, O.; McLaughlin, M.A. Review of cardiovascular risk factors in women. Gend. Med., 2009, 6 (Suppl 1), 17-36.
204. Goldstein, K.M.; Melnyk, S.D.; Zullig, L.L.; Stechuchak, K.M.; Oddone, E.; Bastian, L.A.; Rakley, S.; Olsen, M.K.; Bosworth, H.B. Heart matters: Gender and racial differences cardiovascular disease risk factor control among veterans. Womens Health Issues, 2014, 24 (5), 477-483.
205. Schroeder, E.B.; Bayliss, E.A.; Daugherty, S.L.; Steiner, J.F. Gender differences in cardiovascular risk factors in incident diabetes. Womens Health Issues, 2014, 24 (1), e61-e68.
206. Flink, L.; Mochari-Greenberger, H.; Mosca, L. Gender differences in clinical outcomes among diabetic patients hospitalized for cardiovascular disease. Am. Heart J., 2013, 165 (6), 972-978.
207. Schottker, B.; Muller, H.; Rothenbacher, D.; Brenner, H. Fasting plasma glucose and HbA1c in cardiovascular risk prediction: a sex-specific comparison in individuals without diabetes mellitus. Diabetologia, 2013, 56 (1), 92-100.
208. Meisinger, C.; Doring, A.; Stockl, D.; Thorand, B.; Kowall, B.; Rathmann, W. Uric acid is more strongly associated with impaired glucose regulation in women than in men from the general population: the KORA F4-Study. PLoS One, 2012, 7 (5), e37180.
209. Iozzo, P.; Lautamaki, R.; Borra, R.; Lehto, H.R.; Bucci, M.; Viljanen, A.; Parkka, J.; Lepomaki, V.; Maggio, R.; Parkkola, R.; Knuuti, J.; Nuutila, P. Contribution of glucose tolerance and gender to cardiac adiposity. J. Clin. Endocrinol. Metab., 2009, 94 (11), 4472-4482.
210. Katsiki, N.; Mikhailidis, D.P.; Wierzbicki, A.S. Epicardial fat and vascular risk: a narrative review. Curr. Opin. Cardiol., 2013, 28 (4), 458-463.
211. Razzouk, L.; Muntner, P. Ethnic, gender, and age-related differences in patients with the metabolic syndrome. Curr. Hypertens. Rep., 2009, 11 (2), 127-132.
212. Iyer, A.; Kauter, K.; Brown, L. Gender differences in metabolic syndrome: a key research issue? Endocr. Metab. Immune Disord. Drug Targets, 2011, 11 (3), 182-188.
213. Banos, G.; Guarner, V.; Perez-Torres, I. Sex steroid hormones, cardiovascular diseases and the metabolic syndrome. Cardiovasc. Hematol. Agents Med. Chem., 2011, 9 (3), 137-146.
214. Rochlani, Y.; Pothineni, N.V.; Mehta, J.L. Metabolic Syndrome: does it differ between women and men? Cardiovasc. Drugs Ther., 2015, 29 (4), 329-338.
215. Athyros, V.G.; Ganotakis, E.; Kolovou, G.D. Assessing the treatment effect in metabolic syndrome without perceptible diabetes (ATTEMPT) collaborative. Assessing the treatment effect in metabolic syndrome without perceptible diabetes (ATTEMPT): a prospective-randomized study in middle aged men and women. Curr. Vasc. Pharmacol., 2011, 9, 647-657.
216. Regitz-Zagrosek, V.; Lehmkuhl, E.; Mahmoodzadeh, S. Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease. Gend. Med., 2007, 4 (Suppl B), S162-S177.
217. Stuckey, MI., Tulppo, M.P.; Kiviniemi, A.M.; Petrella, R.J. Heart rate variability and the me; abolic syndrome: a systematic review of the literature. Diabetes Metab. Res. Rev. 2014, 30 (8), 784-793.
218. Boden-Albala, B.; Sacco, R.L.; Lee, H.S.; Grahame-Clarke, C.; Rundek, T.; Elkind, M.V.; Wright, C.; Giardina, E.G.; DiTullio, M.R.; Homma, S.; Paik, M.C. Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study. Stroke, 2008, 39 (1), 30-35.
219. Fan, A.Z. Metabolic syndrome and progression of atherosclerosis among middle-aged US adults. J. Atheroscler. Thromb., 2006, 13 (1), 46-54.
220. Protogerou, A.D.; Blacher, J.; Aslangul, E.; Le Jeunne, C.; Lekakis, J.; Mavrikakis, M.; Safar, M.E. Gender influence on metabolic syndrome's effects on arterial stiffness and pressure wave reflections in treated hypertensive subjects. Atherosclerosis, 2007, 193 (1), 151-158.
221. Fargion, S.; Porzio, M.; Fracanzani, A.L. Nonalcoholic fatty liver disease and vascular disease: state-of-the-art. World J. Gastroenterol., 2014, 20 (37), 13306-13324.
222. Targher, G.; Byrne, C.D. Diagnosis and management of nonalcoholic fatty liver disease and its hemostatic/ thrombotic and vascular complications. Semin. Thromb. Hemost., 2013, 39 (2), 214-228.
223. Pan, J.J.; Fallon, M.B. Gender and racial differences in nonalcoholic fatty liver disease. World J. Hepatol., 2014, 6 (5), 274-283.
224. Neuschwander-Tetri, B.A.; Clark, J.M.; Bass, N.M.; Van Natta, M.L.; Unalp-Arida, A.; Tonascia, J.; Zein, C.O.; Brunt, E.M.; Kleiner, D.E.; McCullough, A.J. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology, 2010, 52, 913-924.
225. Hashimoto, E.; Tokushige, K. Prevalence, gender, ethnic variations, and prognosis of NASH. J. Gastroenterol., 2011, 46 ( Suppl 1), 63-69.
226. Volzke, H.; Schwarz, S.; Baumeister, S.E.; Wallaschofski, H.; Schwahn, C.; Grabe, H.J.; Kohlmann, T.; John, U.; Doren, M. Menopausal status and hepatic steatosis in a general female population. Gut, 2007, 56, 594-595.
227. Suzuki, A.; Abdelmalek, M.F. Nonalcoholic fatty liver disease in women. Womens Health (Lond Engl). 2009, 5 (2), 191-203.
228. Durazzo, M.; Belci, P.; Collo, A.; Prandi, V.; Pistone, E.; Martorana, M.; Gambino, R.; Bo, S. Gender specific medicine in liver diseases: a point of view. World J. Gastroenterol., 2014, 20 (9), 2127-35.
229. Denzer, C;. Thiere, D.; Muche, R.; Koenig, W.; Mayer, H.; Kratzer, W.; Wabitsch, M. Gender-specific prevalences of fatty liver in obese children and adolescents: roles of body fat distribution, sex steroids, and insulin resistance. J. Clin. Endocrinol. Metab., 2009, 94, 3872-3881.
230. Reslan, O.M.; Khalil, R.A. Vascular effects of estrogenic menopausal hormone therapy. Rev. Recent Clin. Trials, 2012, 7 (1), 47-70.
231. Prentice, R.L. Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke. Semin. Reprod. Med., 2014, 32 (6), 419-425.
232. Masood, D.E.; Roach, E.C.; Beauregard, K.G.; Khalil, R.A. Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease. Curr. Drug Metab., 2010, 11 (8), 693-714.
233. Wild, R.A.; Manson. J.E. Insights from the Women's Health Initiative: individualizing risk assessment for hormone therapy decisions. Semin. Reprod. Med. 2014, 32 (6), 433-437.
234. Yang, X.P.; Reckelhoff, J.F. Estrogen, hormonal replacement therapy and cardiovascular disease. Curr. Opin. Nephrol. Hypertens, 2011, 20 (2), 133-138.
235. Bernstein, P.; Pohost, G. Progesterone, progestins, and the heart. Rev. Cardiovasc. Med., 2010, 11 (4), 228-236.
236. Stojanovic, N.D.; Kwong, P.; Byrne, D.J.; Arnold, A.; Jagroop, I.A.; Nair, D.; Press, M.; Hurel, S.; Mikhailidis, D.P.; Prelevic, G.M. The effects of transdermal estradiol alone or with cyclical dydrogesterone on markers of cardiovascular disease risk in postmenopausal women with type 2 diabetes: a pilot study. Angiology, 2003, 54 (4), 391-399.
237. Ostberg, J.E.; Damjanovic, T.; Dimkovic, N.; Byrne, D.; Mikhailidis, D.P.; Prelevic, G.M. Effect of tibolone on markers of cardiovascular disease risk in postmenopausal women undergoing hemodialysis: a pilot study. Fertil. Steril., 2004, 81 (6), 1624-1631.